Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Towards Personalized Chemotherapy in Gastrointestinal Cancers: Prospective Analysis of Pharmacogenetic Variants in a Russian Cohort. | Genes (Basel) | 2025 | 41300713 | PubTator, text mining | PubMed |
| Characterisation of pharmacogenomic variation in the Shetland and Orkney Isles in Scotland. | Sci Rep | 2025 | 41298791 | PubTator, text mining | PubMed |
| Severe toxicity following genotype-guided reduced 5-FU dose in a heterozygous DPYD c.2846A>T carrier with stage III anal carcinoma: A case report. | Cancer Chemother Pharmacol | 2025 | 41269318 | PubTator, text mining | PubMed |
| Letter to the editor: Expanding DPYD genotyping panels beyond current guidelines-real-world evidence and clinical-economic thoughts on inclusion of additional variants. | Br J Clin Pharmacol | 2025 | 41268686 | PubTator, text mining | PubMed |
| Clinical Implications of Dihydropyrimidine Dehydrogenase Deficiency in GI and Hepatopancreaticobiliary Cancers Treated With Fluoropyrimidines: A Prospective Observational Study. | JCO Glob Oncol | 2025 | 41259730 | PubTator, text mining | PubMed |
| Prevalence of uncommon side effects of 5-fluorouracil and capecitabine in Saudi patients with cancer: A cross-sectional observational study. | Medicine (Baltimore) | 2025 | 41189209 | PubTator, text mining | PubMed |
| The Clinical Pharmacogenetics Implementation Consortium's consensus-based framework for assigning allele function. | Am J Hum Genet | 2025 | 41175864 | PubTator, text mining | PubMed |
| Characterization of PANoptosis-based markers for ischemic stroke and their appealing implications in improving prognosis and in glioma patients. | Discov Oncol | 2025 | 41160218 | PubTator, text mining | PubMed |
| Severe fluoropyrimidine toxicity in a patient with rectal adenocarcinoma with DPYD c.2846A>T heterozygous mutation: A case report. | Oncol Lett | 2025 | 41133273 | PubTator, text mining | PubMed |
| Integrating genetic regulation and schizophrenia-specific splicing quantitative expression with GWAS prioritizes novel risk genes for schizophrenia. | Transl Psychiatry | 2025 | 41053005 | PubTator, text mining | PubMed |
| DPYD-guided fluoropyrimidine dose adjustment in colorectal cancer DPYD carriers: start slower to finish stronger. | Front Pharmacol | 2025 | 41050413 | PubTator, text mining | PubMed |
| Dihydropyrimidine Dehydrogenase-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction. | JCO Precis Oncol | 2025 | 41037764 | PubTator, text mining | PubMed |
| Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction. | JCO Precis Oncol | 2025 | 41037763 | PubTator, text mining | PubMed |
| Transcriptomics-based identification of lysine crotonylation-related biomarkers in pre-eclampsia. | BMC Pregnancy Childbirth | 2025 | 41034826 | PubTator, text mining | PubMed |
| [Genotyping of the DPYD Gene: An Ethical and Legal Obligation for the Protection of the Oncology Patient]. | Rev Med Chil | 2025 | 41021863 | PubTator, text mining | PubMed |
| Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil. | Biomed Rep | 2025 | 41020253 | PubTator, text mining | PubMed |
| Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment. | Discov Oncol | 2025 | 41003873 | PubTator, text mining | PubMed |
| Integration of germline pharmacogenomic burden to predict fluoropyrimidine-related toxicity - A secondary analysis of the PREPARE trial. | Oncogene | 2025 | 40999005 | PubTator, text mining | PubMed |
| Advancements in the diagnosis and management of capecitabine-induced hand-foot syndrome. | J Cancer Res Clin Oncol | 2025 | 40976784 | PubTator, text mining | PubMed |
| A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death. | PLoS One | 2025 | 40956795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=6